期刊文献+

肽核酸对大肠癌LS-174T细胞生长抑制作用

Inhibitory effect of peptide nucleic acid on the growth of colorectal cancer LS-174T cells
下载PDF
导出
摘要 目的:探讨肽核酸(peptideorpolyamidenucleicacid,PNA)对大肠癌细胞端粒酶活性的抑制作用及对大肠癌细胞生长的影响.方法:应用脂质体LipfectamineTM介导不同浓度(25,50,100,200,400nmol/L)PNA-DNA杂交混合物转染LS-174T细胞,通过细胞克隆生长抑制试验来测定PNA对细胞生长的最佳抑制剂量;选用最佳抑制剂量PNA转染LS-174T细胞,同时设置脂质体组(LipfectamineTM)组和空白对照组,观察克隆形成率、细胞形态及群体生长差异.结果:PNA对LS-174T细胞最佳抑制浓度为200nmol/L.PNA实验组端粒酶活性和克隆形成率明显低于脂质体组和空白对照组(0.003±0.001vs2.334±0.025,2.528±0.032,P<0.01;5.20%vs45.45%,47.13%,P<0.01).PNA组癌细胞生长出现典型形态学改变,细胞变圆、胞膜皱缩、细胞核边集于核膜,通过群体生长曲线,转染后11d出现抑制作用,15、17d抑制作用最显著.结论:体外试验中PNA对大肠癌LS-174T细胞生长有明显的抑制作用,其作用机制可能是PNA对大肠癌细胞端粒酶活性的抑制. AIM: To explore the inhibitory effect of peptide nucleic acid (PNA) on the telomerase activity and the growth of colorectal cancer cells. METHODS: LS-174T cells were transfected with the mixture of PNA-DNA at different concentrations (25, 50, 100, 200, 400 nmol/L) mediated by LipfectamineTM. Cell cloning experiment was used to select the best inhibition concentration of PNA, and then LS-174T cells were transfected with this concentration. At the same time, liposome (using LipfectamineTM) group and empty control group were established. The clone formation rate, cancer cell morphology and group growth difference were compared between groups. RESULTS: Cell cloning experiment identified that the best inhibition concentration was 200 nmol/L. The telomerase activity and clone formation rate were notably lower in PNA-transfected group than those in Lipfectamine^TM and empty control group (0.003 ± 0.001 vs 2.334 ± 0.025, 2.528 ± 0.032, P 〈 0.01; 5.20% vs 45.45%, 47.13%, P 〈 0.01). In the PNA-transfected group, cancer cells showed typical morphological changes, such as becoming round, membrane shrinkage, and nucli concentrating at karyotheca, etc. Group growth curve manifested that the inhibition emerges 11 d after transfection and became notable 15 d or 17 d later. CONCLUSION: PNA can inhibit the growth of LS-174T cells obviously through suppressing telomerase activity.
出处 《世界华人消化杂志》 CAS 北大核心 2008年第11期1179-1183,共5页 World Chinese Journal of Digestology
关键词 肽核酸 端粒酶 转染 大肠癌 Peptide nucleic acid Telomerase Transfection Colorectal cancer
  • 相关文献

参考文献4

二级参考文献40

  • 1瞿秋霞,陈永井,葛彦,王勤,陈成,杨明峰,张学光.抗人CD40人-鼠嵌合抗体的构建及其表达[J].细胞与分子免疫学杂志,2006,22(2):189-192. 被引量:10
  • 2[1]Thibodeau SN,Bren G,Schaid D.Microsatellite instability in cancer of the proximal colon.Science 1993; 260:816-819
  • 3[2]Gryfe R,Kim H,Hsieh ET,Aronson MD,Holowaty EJ,Bull SB,Redston M,Gallinger S.Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer.N Engl J Med 2000; 342:69-77
  • 4[3]Wright CM,Dent OF,Barker M,Newland RC,Chapuis PH,Bokey EL,Young JP,Leggett BA,Jass JR,Macdonald GA.Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer.Br J Surg 2000; 87:1197-1020
  • 5[4]Samowitz WS,Sweeney C,Herrick J,Albertsen H,Levin TR,Murtaugh MA,Wolff RK,Slattery ML.Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers.Cancer Res 2005; 65:6063-6069
  • 6[5]Shay JW,Bacchetti S.A survey of telomerase activity in human cancer.Eur J Cancer 1997; 33:787-789
  • 7[6]Dunham MA,Neumann AA,Fasching CL,Reddel RR.Telomere maintenance by recombination in human cells.Nat Genet 2000; 26:447-450
  • 8[7]Tatsumoto N,Hiyama E,Murakami Y,Imamura Y,Shay JW,Matsuura Y,Yokoyama T.High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer.Clin Cancer Res 2000; 6:2696-2701
  • 9[8]Shoji Y,Yoshinaga K,Inoue A,Iwasaki A,Sugihara K.Quantification of telomerase activity in sporadic colorectal carcinoma:association with tumor growth and venous invasion.Cancer 2000; 88:1304-1309
  • 10[9]Kawanishi-Tabata R,Lopez F,Fratantonio S,Kim N,Goldblum J,Tubbs R,Elson P,Lavery I,Bukowski RM,Ganapathi R,Ganapathi MK.Telomerase activity in stage Ⅱ colorectal carcinoma.Cancer 2002; 95:1834-1839

共引文献106

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部